{
  "id": 3880914,
  "title": "Daewoong Pharmaceutical Builds Digital Healthcare Alliance Around AI Diagnostics and Patient Monitoring",
  "url": "https://urgent.news/2026/08/28/daewoong-pharmaceutical-builds-digital-healthcare-alliance-around-ai",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-28T03:56:16.000Z",
  "source": {
    "name": "Korea IT Times",
    "slug": "korea-it-times",
    "url": "https://www.koreaittimes.com/news/articleView.html?idxno=156528"
  },
  "original_language": "en",
  "account": "Daewoong Pharmaceutical is creating a digital healthcare alliance that integrates 12 Korean health-tech companies, focusing on AI diagnostics, wearable devices, digital therapeutics, and patient monitoring. This strategy was showcased at KHF (K-Hospital Health Tech Fair) 2026 in Seoul, where Daewoong presented its \"DAEWOONG Alliance\" platform designed to connect technologies throughout the patient journey, from prevention and prediction to post-treatment monitoring. The alliance aims to transition Daewoong from a drug developer to a connector of technology companies, medical institutions, and patients.\n\nThe alliance is centered around four stages of healthcare: prevention and prediction, early diagnosis, treatment, and post-treatment monitoring and clinical efficiency. During KHF 2026, the alliance featured a 20-booth exhibition area and 34 expert sessions, attracting around 23,000 visitors and 700 attendees. The alliance could play a significant role in the commercialization of digital health technologies, offering benefits to both Daewoong and the participating health-tech companies. Daewoong's extensive medical network, built over decades, could facilitate the adoption of partner technologies by hospitals and clinics, making the alliance a more significant commercialization platform than simply a portfolio of investments or distribution agreements.",
  "summary": "Daewoong Pharmaceutical is expanding beyond its traditional drug business by building a digital healthcare ecosystem that connects 12 Korean health-tech companies across AI diagnostics, wearable devices, digital therapeutics and patient monitoring.The strategy was put on display at KHF (K-Hospital H",
  "key_points": [
    "Daewoong Pharmaceutical forms 12-Korean health-tech alliance",
    "Focus on AI diagnostics, wearables, digital therapeutics, patient monitoring",
    "Aims to transition from drug developer to technology connector"
  ],
  "editors_take": "Daewoong Pharmaceutical's digital healthcare alliance shifts its business model from drug development to connecting technology companies, medical institutions, and patients, leveraging its extensive medical network for commercialization.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}